Clinical Trial 4860

Boston, MA 02108


Study Summary:

Individuals with colorectal cancer that has metastasized (spread) are invited to inquire about participation in a clinical research study. This study will evaluate a fully human monoclonal antibody combined with chemotherapy to see if it will extend survival for a longer period of time, compared to the best available standard treatment regimen. Monoclonal antibodies are substances produced in a laboratory that can locate and bind to cancer cells by recognizing specific substances on cancer cells. These antibodies are used to find and attack tumors.


Qualified Participants Must:

• Have unresectable (inoperable) colorectal cancer that has metastasized (spread)
• Be at least 18 years of age
• Not have received a prior treatment regimen for their advanced-stage colorectal cancer
• Meet other enrollment criteria


Qualified Participants May Receive:

Study-related medication and medical examinations at no cost


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.